Jeffrey A Medin, PhD
The laboratory of Jeffrey A. Medin, PhD, has three main areas of focus: to develop novel cancer immunotherapy strategies; to investigate the pathophysiology of, and develop treatments for, Lysosomal Storage Disorders (LSD); and to create a facility dedicated to the manufacture of FDA approved gene therapy vector to be used by investigators to ‘pipeline’ novel therapies from conception to testing to clinical trial implementation.
Education and Awards
- 1991, University of Kentucky, PhD
- 1985, University of Wisconsin- Parkside, BS